GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G&E Healthcare Co Ltd (XKRX:299480) » Definitions » Change In Receivables

G&E Healthcare Co (XKRX:299480) Change In Receivables : ₩0.00 Mil (TTM As of . 20)


View and export this data going back to 2018. Start your Free Trial

What is G&E Healthcare Co Change In Receivables?

G&E Healthcare Co's change in receivables for the quarter that ended in . 20 was ₩0.00 Mil. It means G&E Healthcare Co's Accounts Receivable stayed the same from . 20 to . 20 .

G&E Healthcare Co's change in receivables for the fiscal year that ended in . 20 was ₩0.00 Mil. It means G&E Healthcare Co's Accounts Receivable stayed the same from . 20 to . 20 .

G&E Healthcare Co's Accounts Receivable for the quarter that ended in . 20 was ₩0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. G&E Healthcare Co's liquidation value for the six months ended in . 20 was ₩0.00 Mil.


G&E Healthcare Co Change In Receivables Historical Data

The historical data trend for G&E Healthcare Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G&E Healthcare Co Change In Receivables Chart

G&E Healthcare Co Annual Data
Trend
Change In Receivables

G&E Healthcare Co Semi-Annual Data
Change In Receivables

G&E Healthcare Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in . 20 was ₩0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


G&E Healthcare Co  (XKRX:299480) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

G&E Healthcare Co's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:

2. In Ben Graham's calculation of liquidation value, G&E Healthcare Co's accounts receivable are only considered to be worth 75% of book value:

G&E Healthcare Co's liquidation value for the quarter that ended in . 20 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


G&E Healthcare Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of G&E Healthcare Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


G&E Healthcare Co (XKRX:299480) Business Description

Traded in Other Exchanges
N/A
Address
No. 92, Keji 5th Road, Annan District, Tainan, TWN, 70955
G&E Healthcare Co Ltd, formerly G&E Biotech Co Ltd is a biopharmaceutical company focused on the development and commercialization of novel botanical extraction technology and products. It offers a range of products that include Hepato Protective Agent (Hepanamin) which prevent and cure for acute and chronic hepatitis, fatty liver conditions and liver toxicity infections, Botanical Healthcare product, and Botanical Anti-aging cosmetics.

G&E Healthcare Co (XKRX:299480) Headlines

No Headlines